SOUTHWELL DAVID P
SEC CIK 1251553 · EDGAR
BoughtSold
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
| 14 | SOUTHWELL DAVID P | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 20:45 | 2026-08-03 | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | J - Other | $0.00 | +150.0K | 204.5K | +275% | $0 | |
| D | 2026-07-06 19:59 | 2026-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +22.9K | 54.5K | +72% | $0 |
| D | 2026-01-06 | 2026-01-02 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +4,000 | 20.9K | +24% | $0 |
| D | 2025-09-11 | 2025-09-09 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | S - Sale+OE | $58.34 | -12.0K | 16.9K | -42% | -$700.1K |
| D | 2025-09-11 | 2025-09-09 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | M - OptEx | $30.86 | +12.0K | 28.9K | +71% | +$370.3K |
| 2025-07-18 | 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +30.0K | 31.7K | +1,807% | $0 | |
| D | 2025-01-07 | 2025-01-03 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +4,000 | 16.9K | +31% | $0 |
| 2024-05-20 | 2024-05-02 | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | G - Gift | $0.00 | -113.1K | 1,660 | -99% | $0 | |
| I | 2024-05-20 | 2024-05-02 | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | G - Gift | $0.00 | -59.7K | 113.1K | -35% | $0 |
| 2024-05-10 | 2024-05-08 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | G - Gift | $0.00 | -1,650 | 12.8K | -11% | $0 | |
| DM | 2024-04-16 | 2024-04-12+ | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | M - OptEx | $4.34 | +99.6K | 124.8K | +396% | +$432.4K |
| DM | 2024-04-16 | 2024-04-12+ | RCKT | ROCKET PHARMACEUTICALS, INC. | SOUTHWELL DAVID P | Dir | S - Sale+OE | $24.32 | -80.0K | 95.2K | -46% | -$1.95M |
| D | 2024-02-16 | 2024-02-15 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +4,000 | 14.5K | +38% | $0 |
| DM | 2023-04-19 | 2023-04-17 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | S - Sale+OE | $51.03 | -11.4K | 10.5K | -52% | -$583.2K |
| D | 2023-04-19 | 2023-04-17 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | M - OptEx | $18.01 | +11.4K | 21.9K | +109% | +$205.8K |
| D | 2023-04-04 | 2023-03-31 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | M - OptEx | $18.01 | +2,571 | 13.1K | +24% | +$46.3K |
| D | 2023-04-04 | 2023-03-31 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | S - Sale+OE | $50.05 | -2,571 | 10.5K | -20% | -$128.7K |
| DM | 2023-03-29 | 2023-03-27 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | S - Sale+OE | $45.09 | -10.0K | 10.6K | -49% | -$450.9K |
| D | 2023-03-29 | 2023-03-27 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | M - OptEx | $27.05 | +10.0K | 20.5K | +95% | +$270.5K |
| D | 2023-01-09 | 2023-01-05 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +4,000 | 10.5K | +62% | $0 |
| M | 2022-05-20 | 2022-05-18 | TCRX | TScan Therapeutics, Inc. | SOUTHWELL DAVID P | CEO, Dir | P - Purchase | $3.59 | +25.0K | 171.6K | +17% | +$89.8K |
| D | 2022-01-11 | 2022-01-07 | PTCT | PTC THERAPEUTICS, INC. | SOUTHWELL DAVID P | Dir | A - Grant | $0.00 | +3,200 | 6,500 | +97% | $0 |
| D | 2021-12-27 | 2021-12-23 | TCRX | TScan Therapeutics, Inc. | SOUTHWELL DAVID P | CEO, Dir | M - OptEx | $1.97 | +48.7K | 146.6K | +50% | +$95.9K |
| 2021-09-09 | 2021-09-08 | TCRX | TScan Therapeutics, Inc. | SOUTHWELL DAVID P | CEO, Dir | P - Purchase | $8.73 | +11.0K | 97.9K | +13% | +$96.0K |
Purchase Sale Sale after option exercise All abbreviations